Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 39.45
-0.55 (-1.38%)
Sep 9, 2025, 1:35 PM CST
Nang Kuang Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 268.54 | 243.41 | 198.41 | 352 | 196.11 | 183.4 | Upgrade |
Depreciation & Amortization | 184.04 | 182.96 | 181.96 | 176.28 | 179.75 | 185.29 | Upgrade |
Loss (Gain) From Sale of Assets | 4.18 | -0.17 | -6.1 | 0.05 | 0.15 | - | Upgrade |
Loss (Gain) From Sale of Investments | 43.65 | 23.07 | 1.85 | -70.49 | 2.22 | 7.33 | Upgrade |
Provision & Write-off of Bad Debts | -1.12 | -2.67 | 78.83 | 2.14 | 1.97 | 0.27 | Upgrade |
Other Operating Activities | 30.99 | 27.53 | 2.43 | 4.54 | 44.65 | -4.84 | Upgrade |
Change in Accounts Receivable | -24.13 | -52.17 | -61.46 | -29.37 | 12.95 | 3.06 | Upgrade |
Change in Inventory | 25.92 | 75.44 | 71.53 | -130.21 | 80.13 | -189.06 | Upgrade |
Change in Accounts Payable | 8.96 | 43.77 | -87.53 | 30.33 | 36.01 | -38.37 | Upgrade |
Change in Unearned Revenue | -14.35 | -4.07 | -14.53 | 10.95 | 10.17 | 4.5 | Upgrade |
Change in Other Net Operating Assets | 33.97 | -70.67 | -22.78 | 22.97 | -7.47 | -0.57 | Upgrade |
Operating Cash Flow | 560.65 | 466.43 | 342.61 | 369.19 | 556.63 | 151.01 | Upgrade |
Operating Cash Flow Growth | 43.05% | 36.14% | -7.20% | -33.67% | 268.61% | -60.90% | Upgrade |
Capital Expenditures | -469.56 | -524.6 | -297.51 | -93.84 | -156.05 | -90.14 | Upgrade |
Sale of Property, Plant & Equipment | 0.11 | 16.01 | 6.53 | 0.24 | 0.05 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.82 | -1.32 | -3.22 | -0.33 | -3.69 | -1.55 | Upgrade |
Investment in Securities | - | 135 | -33.75 | 1.78 | -129.2 | -25.21 | Upgrade |
Other Investing Activities | -0.05 | 2.51 | -1.55 | -17.7 | -2.59 | 4.89 | Upgrade |
Investing Cash Flow | -470.32 | -372.39 | -329.51 | -109.85 | -291.48 | -112.01 | Upgrade |
Short-Term Debt Issued | - | 2,220 | 2,520 | 2,810 | 2,475 | 3,113 | Upgrade |
Long-Term Debt Issued | - | 175.22 | - | - | - | 50 | Upgrade |
Total Debt Issued | 3,034 | 2,395 | 2,520 | 2,810 | 2,475 | 3,163 | Upgrade |
Short-Term Debt Repaid | - | -2,350 | -2,310 | -2,920 | -2,375 | -3,103 | Upgrade |
Long-Term Debt Repaid | - | -13.94 | -13.55 | -13.8 | -52.9 | -52.8 | Upgrade |
Total Debt Repaid | -2,858 | -2,364 | -2,324 | -2,934 | -2,428 | -3,156 | Upgrade |
Net Debt Issued (Repaid) | 176.49 | 31.28 | 196.45 | -123.8 | 47.1 | 7.2 | Upgrade |
Common Dividends Paid | -201.98 | -201.98 | -232.27 | -181.78 | -161.58 | -171.68 | Upgrade |
Other Financing Activities | - | -0.27 | 0.06 | 30.27 | - | - | Upgrade |
Financing Cash Flow | -25.48 | -170.97 | -35.77 | -275.31 | -114.48 | -164.48 | Upgrade |
Foreign Exchange Rate Adjustments | -0 | -0 | -0.06 | 0.06 | -0.01 | -0.01 | Upgrade |
Net Cash Flow | 64.84 | -76.93 | -22.73 | -15.92 | 150.66 | -125.49 | Upgrade |
Free Cash Flow | 91.09 | -58.17 | 45.1 | 275.35 | 400.58 | 60.87 | Upgrade |
Free Cash Flow Growth | - | - | -83.62% | -31.26% | 558.08% | -80.44% | Upgrade |
Free Cash Flow Margin | 4.00% | -2.64% | 2.10% | 14.19% | 22.50% | 3.47% | Upgrade |
Free Cash Flow Per Share | 0.90 | -0.57 | 0.45 | 2.72 | 3.96 | 0.60 | Upgrade |
Cash Interest Paid | 7.6 | 5.6 | 7.06 | 4.81 | 3.5 | 4.33 | Upgrade |
Cash Income Tax Paid | 31.18 | 33.88 | 83.07 | 44.65 | 16.14 | 53.52 | Upgrade |
Levered Free Cash Flow | -54.59 | -165.25 | 150.61 | 192.96 | 332.75 | 9.01 | Upgrade |
Unlevered Free Cash Flow | -49.83 | -161.79 | 155.1 | 195.98 | 334.96 | 11.7 | Upgrade |
Change in Working Capital | 30.38 | -7.7 | -114.77 | -95.34 | 131.79 | -220.44 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.